Optimi Health Announces Closing of Non-Brokered Private Placement and Debt Settlement @Optimi_Health #MDMA #psilocybin #psychedelics #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Financing #PrivatePlacement #CSEStocks #SmallCaps #Investing
Vancouver, British Columbia--(Newsfile Corp. - January 28, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-approved, Health Canada licensed psychedelics pharmaceutical manufacturer specializing in botanical psilocybin and MDMA, announces it has closed the second and final tranche (the "Second Tranche") of its non-brokered private placement (the "Offering") of units of the Company (each, a "Unit") at a price of $0.30 per Unit. Under the Second...
http://dlvr.it/THf1Jw
http://dlvr.it/THf1Jw
Comments
Post a Comment